financetom
AMPH
financetom
/
Healthcare
/
AMPH
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Amphastar Pharmaceuticals, Inc.AMPH
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API).

It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.

The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures.

In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock.

Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices.

The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Latest News >
Pound Sterling Faces Bank of England Test Nursing Losses against the Euro and Dollar
Pound Sterling Faces Bank of England Test Nursing Losses against the Euro and Dollar
Mar 22, 2024
- GBP has fallen steadily this week - Bank of England policy decision at 12:00 BST - Comes amidst surging UK gas prices - Bank might opt to ignore surging inflation Image © Adobe Stock Market rates at publication: GBP/EUR: 1.1650 | GBP/USD: 1.3647Bank transfer rates: 1.1420 | 1.3365Specialist transfer...
Pound Sterling to Push Higher against Euro says SEB
Pound Sterling to Push Higher against Euro says SEB
Mar 22, 2024
- GBP's strong 2021 is not done says SEB - BoE to propel further gains with May rate hike - But some economists warn of disappointment - See first rate hike as late as 2023 Image © Adobe Images Market rates at publication: GBP/EUR: 1.1698 | GBP/USD: 1.3705Bank transfer rates:...
Pound Sterling and the Adzuna Signal: Toscafund on Why the UK Currency can Move Significantly Higher
Pound Sterling and the Adzuna Signal: Toscafund on Why the UK Currency can Move Significantly Higher
Mar 22, 2024
- GBP/USD towards 1.90? - GBP/EUR towards 1.40? - Forget GDP, CPI data - Job vacancies tell the real story Image © Pound Sterling Live Market rates at publication: GBP/EUR: 1.1647 | GBP/USD: 1.3660Bank transfer rates: 1.1420 | 1.3380Specialist transfer rates: 1.1589 | 1.35900Get a bank-beating exchange rate quote, hereSet...
Pound Sterling to Stabilise Alongside Gas Prices and Broader Market
Pound Sterling to Stabilise Alongside Gas Prices and Broader Market
Mar 22, 2024
- GBP is worst performing major - UK energy crisis cited - Gas prices surge as Russia strangles supply - Declines exacerbated by Evergrande concerns Image © Adobe Images Market rates at publication: GBP/EUR: 1.1647 | GBP/USD: 1.3670Bank transfer rates: 1.1420 | 1.3390Specialist transfer rates: 1.1589 | 1.3600Get a bank-beating...
Copyright 2023-2025 - www.financetom.com All Rights Reserved